20-51791838-G-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_020436.5(SALL4):​c.645C>G​(p.Leu215Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0278 in 1,614,128 control chromosomes in the GnomAD database, including 755 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.021 ( 55 hom., cov: 33)
Exomes 𝑓: 0.029 ( 700 hom. )

Consequence

SALL4
NM_020436.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.603

Publications

8 publications found
Variant links:
Genes affected
SALL4 (HGNC:15924): (spalt like transcription factor 4) This gene encodes a zinc finger transcription factor thought to play a role in the development of abducens motor neurons. Defects in this gene are a cause of Duane-radial ray syndrome (DRRS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]
SALL4 Gene-Disease associations (from GenCC):
  • Duane-radial ray syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • Duane retraction syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • IVIC syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 20-51791838-G-C is Benign according to our data. Variant chr20-51791838-G-C is described in ClinVar as Benign. ClinVar VariationId is 261265.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.603 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0206 (3132/152348) while in subpopulation NFE AF = 0.0334 (2272/68034). AF 95% confidence interval is 0.0323. There are 55 homozygotes in GnomAd4. There are 1507 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 3132 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020436.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SALL4
NM_020436.5
MANE Select
c.645C>Gp.Leu215Leu
synonymous
Exon 2 of 4NP_065169.1
SALL4
NM_001318031.2
c.645C>Gp.Leu215Leu
synonymous
Exon 2 of 4NP_001304960.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SALL4
ENST00000217086.9
TSL:1 MANE Select
c.645C>Gp.Leu215Leu
synonymous
Exon 2 of 4ENSP00000217086.4
SALL4
ENST00000395997.3
TSL:1
c.645C>Gp.Leu215Leu
synonymous
Exon 2 of 4ENSP00000379319.3
SALL4
ENST00000371539.7
TSL:1
c.131-2697C>G
intron
N/AENSP00000360594.3

Frequencies

GnomAD3 genomes
AF:
0.0206
AC:
3133
AN:
152230
Hom.:
55
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00499
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0133
Gnomad ASJ
AF:
0.0164
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0281
Gnomad FIN
AF:
0.0210
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0334
Gnomad OTH
AF:
0.0129
GnomAD2 exomes
AF:
0.0232
AC:
5832
AN:
250948
AF XY:
0.0243
show subpopulations
Gnomad AFR exome
AF:
0.00427
Gnomad AMR exome
AF:
0.00917
Gnomad ASJ exome
AF:
0.0144
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0206
Gnomad NFE exome
AF:
0.0343
Gnomad OTH exome
AF:
0.0228
GnomAD4 exome
AF:
0.0286
AC:
41777
AN:
1461780
Hom.:
700
Cov.:
89
AF XY:
0.0288
AC XY:
20912
AN XY:
727200
show subpopulations
African (AFR)
AF:
0.00397
AC:
133
AN:
33480
American (AMR)
AF:
0.00901
AC:
403
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0163
AC:
425
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.0281
AC:
2425
AN:
86258
European-Finnish (FIN)
AF:
0.0208
AC:
1110
AN:
53316
Middle Eastern (MID)
AF:
0.0173
AC:
100
AN:
5768
European-Non Finnish (NFE)
AF:
0.0320
AC:
35591
AN:
1112006
Other (OTH)
AF:
0.0263
AC:
1588
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
2798
5596
8394
11192
13990
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1224
2448
3672
4896
6120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0206
AC:
3132
AN:
152348
Hom.:
55
Cov.:
33
AF XY:
0.0202
AC XY:
1507
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.00498
AC:
207
AN:
41584
American (AMR)
AF:
0.0133
AC:
203
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0164
AC:
57
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.0282
AC:
136
AN:
4830
European-Finnish (FIN)
AF:
0.0210
AC:
223
AN:
10618
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0334
AC:
2272
AN:
68034
Other (OTH)
AF:
0.0128
AC:
27
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
170
341
511
682
852
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0223
Hom.:
18
Bravo
AF:
0.0181
Asia WGS
AF:
0.00837
AC:
29
AN:
3478
EpiCase
AF:
0.0296
EpiControl
AF:
0.0290

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Duane-radial ray syndrome Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
0.64
DANN
Benign
0.69
PhyloP100
-0.60
Mutation Taster
=91/9
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61737139; hg19: chr20-50408377; API